Evidence map›Paper›PMID 41169953›Full record

ArticleGynecologic oncology reports2025

Percutaneous transesophageal gastrostomy in gynecologic oncology patients with symptomatic malignant bowel obstruction: A case series.

Leslie Panella, Megan Gorman, Divya Gowthaman, Gary L Goldberg, Marina Frimer, Daniel Putterman, Jill S Whyte

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leslie PanellaDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.
Megan GormanDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.
Divya GowthamanDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.
Gary L GoldbergDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.
Marina FrimerDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.
Daniel PuttermanDepartment of Interventional Radiology, Long Island Jewish Medical Center, Northwell Health, United States.
Jill S WhyteDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology, Long Island Jewish Medical Center, Northwell Health, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Malignant bowel obstruction (MBO) is a frequent complication in patients with advanced gynecologic malignancies. Percutaneous transesophageal gastrostomy tubes (PTEG) were developed as an alternative in patients when percutaneous endoscopic gastrostomy (PEG) is technically difficult or clinically contraindicated. Clinical cases: Here we present three cases of women with gynecologic cancers with MBO who failed conservative or medical management and had a PTEG placed for palliative gastric decompression. No major complications were noted. Materials and methods: The procedures were successfully performed under general anesthesia by Interventional Radiologists. Under ultrasound and fluoroscopic guidance, a multipurpose drainage catheter was placed through the neck into the esophagus and positioned into the stomach. The catheter was then connected to drainage. Technical success was achieved in all the patients. Discussion: There are few palliative options for gastric decompression in patients who have advanced gynecologic malignancies. Both PEG and long-term nasogastric tube use have well-documented complications, especially in patients with large tumor burden and ascites. PTEG has been developed as a safe alternative with a low rate of complications and effective symptomatic relief in this patient population.

Indexed as

Gastrostomy tubeInterventional radiologyMalignant bowel obstructionOvarian cancer

Identifiers

PMID41169953
PMCPMC12570089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.